Sort
25,944 grants matching “neurodegeneration”
Alternative Vacuolar Targeting Mechanisms in Yeast
$742,327Daniel J. Klionsky · University Of Michigan At Ann Arbor · R01 · FY2011 · GM
Air Pollution, the Aging Brain and Alzheimer's Disease
$742,286Gail Li · University Of Washington · R01 · FY2018 · ES
Investigating neuroanatomical underpinnings of apathy in ADRD through neuroimaging and electrical manipulation
$742,127Nora Vanegas-Arroyave · Baylor College Of Medicine · R01 · FY2024 · MH
TREM2-mediated microglial dynamic function in Alzheimer disease
$742,112Na Zhao · Mayo Clinic Jacksonville · R01 · FY2024 · AG
TREM2-mediated microglial dynamic function in Alzheimer disease
$742,112Na Zhao · Mayo Clinic Jacksonville · R01 · FY2023 · AG
TREM2-mediated microglial dynamic function in Alzheimer disease
$742,112Guojun Bu · Mayo Clinic Jacksonville · R01 · FY2021 · AG
TREM2-mediated microglial dynamic function in Alzheimer disease
$742,112Na Zhao · Mayo Clinic Jacksonville · R01 · FY2022 · AG
Sphingolipid Biology of Neurodegeneration
$742,052Richard Proia · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Using Transport to Map the Brain
$741,980Elaine L Bearer · University Of New Mexico · R01 · FY2010 · NS
Anti-inflammatory signals and neurodegeneration
$741,976Bruno Conti · San Diego Biomedical Research Institute · R01 · FY2024 · NS
Transcriptomic and Circuitry Aberrations in Alzheimerâs Disease
$741,733Zhen Yan · State University Of New York At Buffalo · R01 · FY2024 · AG
Molecular Characterization of ALS/FTD in a novel C9orf72 BAC mouse model.
$741,646Laura Pw Ranum · University Of Florida · R01 · FY2018 · NS
Development of EP2 receptor antagonists for suppression of Alzheimer's neuropathology
$741,585Thota Ganesh · Emory University · U01 · FY2017 · AG
Endosome Dysfunction in Alzheimer's Disease
$741,201Ralph A. Nixon · New York University School Of Medicine · R01 · FY2020 · AG
Small molecule Parkin activators to treat Alzheimer's Disease
$741,032Feng Wang · Progenra, Inc. · R44 · FY2017 · AG
Safety and modulation of ABCC9 pathways by nicorandil for the treatment of hippocampal sclerosis of aging
$740,936Gregory A Jicha · University Of Kentucky · R01 · FY2021 · AG
Reversal of HIV latency by METH and Inflammation
$740,914Jonathan Karn · Case Western Reserve University · R01 · FY2018 · DA
Brain signature of SARS-CoV-2 Infection and its impact on long-term cognitive functioning in older adults
$740,897Giovanni Schifitto · University Of Rochester · R01 · FY2024 · AG
Cryptic exon splicing mediated by TDP-43 loss of function as the underlying mechanism of pathogenesis in FTLD-TDP
$740,872Aaron D. Gitler · Stanford University · U54 · FY2025 · NS
Identification of small molecules for neurological complications of HIV and substance abuse comorbidity
$740,742Pietro P Sanna · Scripps Research Institute, The · R01 · FY2020 · DA
Establishment of a transgenic monkey of Huntingtons's diesease
$740,714Anthony Wing Sang Chan · Emory University · R24 · FY2010 · RR
Targeting language-specific and executive-control networks with transcranial direct current stimulation in aphasic AD
$740,584Kyrana Tsapkini · Johns Hopkins University · R01 · FY2025 · AG
Computational Drug Repurposing for AD/ADRD with Integrative Analysis of Real World Data and Biomedical Knowledge
$740,268Fei Wang · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AG
Dorsal Column Stimulation as a New Therapy for Motor Disorders
$740,239Miguel A. L. Nicolelis · Duke University · R01 · FY2013 · NS
Investigating neuroanatomical underpinnings of apathy in ADRD through neuroimaging and electrical manipulation
$740,147Nora Vanegas-Arroyave · Baylor College Of Medicine · R01 · FY2021 · MH